Diseases & Disorders
(G12)
IRS Verified
DX Registered
990 on File
LUNG CANCER FOUNDATION OF AMERICA
Financial strength (30%)
77/100
Reliability (20%)
50/100
Effectiveness (25%)
69/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
LCFA’s mission is the dramatic improvement in survivorship of lung cancer patients through the funding of transformative science, with the ultimate goal of curing the disease.
Financial Overview — FY 2024
$2.3M
Total Revenue
$2.1M
Total Expenses
$1.5M
Net Assets
7
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
92.8%
Fundraising Efficiency
N/A
Operating Reserve
8.62x
Liability-to-Asset
28.8%
Revenue Diversification
98.6%
Executive Compensation
$314K
Compared with Peers
FY 2024
Compared with 638 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
92.8% | 82.3% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
2.4% | 11.5% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
4.7% | 2.8% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
8.6 mo | 11.4 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
28.8% | 12.7% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
98.6% | 91.5% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
3.0% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
13.1% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
10.2% | 2.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $2.3M | $2.1M | $1.5M | 92.8% | 7 |
| 2023 | $2.3M | $1.9M | $1.3M | 89.4% | 6 |
| 2022 | $1.5M | $1.5M | $857K | 91.2% | 5 |
| 2021 | $1.3M | $1.1M | N/A | — | 4 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.